Title |
Titrated oral misoprostol for augmenting labour to improve maternal and neonatal outcomes
|
---|---|
Published in |
Cochrane database of systematic reviews, September 2013
|
DOI | 10.1002/14651858.cd010648.pub2 |
Pubmed ID | |
Authors |
Joshua P Vogel, Helen M West, Therese Dowswell |
Abstract |
Labour dystocia is associated with a number of adverse maternal and neonatal outcomes. Augmentation of labour is a commonly used intervention in cases of labour dystocia. Misoprostol is an inexpensive and stable prostaglandin E1 analogue that can be administered orally, vaginally, sublingually or rectally. Misoprostol has proven to be effective at stimulating uterine contractions although it can have serious, and even life-threatening side-effects. Titration refers to the process of adjusting the dose, frequency, or both, of a medication on the basis of frequent review to achieve optimal outcomes. Studies have reported on a range of misoprostol titration regimens used for labour induction and titrated misoprostol may potentially be effective and safe for augmentation of labour. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Indonesia | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 1 | 50% |
Members of the public | 1 | 50% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Ethiopia | 1 | <1% |
Brazil | 1 | <1% |
Unknown | 199 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 36 | 18% |
Student > Ph. D. Student | 23 | 11% |
Student > Bachelor | 22 | 11% |
Researcher | 17 | 8% |
Other | 8 | 4% |
Other | 26 | 13% |
Unknown | 69 | 34% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 76 | 38% |
Nursing and Health Professions | 21 | 10% |
Social Sciences | 11 | 5% |
Psychology | 5 | 2% |
Agricultural and Biological Sciences | 3 | 1% |
Other | 11 | 5% |
Unknown | 74 | 37% |